Photo from wikipedia
2018 has been a year of substantial progress in multiple sclerosis research, with breakthroughs in experimental medicine and translational research. Advances have ranged from successful clinical trials to new reports… Click to show full abstract
2018 has been a year of substantial progress in multiple sclerosis research, with breakthroughs in experimental medicine and translational research. Advances have ranged from successful clinical trials to new reports of promising biomarkers and improved understanding of the pathophysiology of multiple sclerosis. Overall, the findings from multiple sclerosis research in 2018 hold great promise for the treatment of progressive multiple sclerosis and for the availability of new biomarkers to monitor disease progression.
Journal Title: The Lancet Neurology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!